FDA-approved cord blood therapy demonstrates faster recovery and high survival rates. A clinical trial led by the National Institutes of Health (NIH) reported that an experimental stem cell…
Read MoreStem Cell Therapy
FDA Approves Cell Therapy for Blood Cancer Patients
Cell therapy has the potential to reduce the risk of infection after stem cell transplants. The U.S. Food and Drug Administration (FDA) recently approved Omisirge (omidubicel-onlv), a donor-modified…
Read More